Bioenvision to test efficacy of cancer treatment
19th Nov 2005, 05:48 GMT
Cancer focused biopharmaceutical Bioenvision has enrolled the first patients into its efficacy studies of its licensed breast cancer therapy Modrenal.
Bioenvision to test efficacy of cancer treatment related news:
- Young Breast Cancer Patients Often Face Infertility During, After Treatment, USA Today Reports — Medical News Today RSS/XML Feed
- Vanderbilt-Ingram Cancer Center testing new lung cancer treatment — bizjournals.com Health Care:Pharmaceuticals headlines
- Australian prostate cancer drug shows promise — KeralaNext: Science
- Fighting cancer with fever — The Cancer Blog
- Kids can make cancer treatment choices — Blogging Baby
- Spectrum Pharmaceuticals Presents Data at the AACR-NCI-EORTC Meeting That SPI-1620 Significantly Enhances the Anti-Tumor Efficacy of Paclitaxel in Breast Tumor Model — Radiology News from StratCenter.com
- Role of melatonin in cancer treatment is looking compelling — Medical News Today RSS/XML Feed
- Cancer screening: Too old to test? — Business Times Online - All The Headlines
- Newly identified protein may help improve treatment for lung cancer — News-Medical News Feed
- EGFR Inhibitors: What Have We Learned From the Treatment of Lung Cancer? — Medscape Pulmonary Medicine Headlines
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol